NewsDialy

HHS moves to allow unapproved peptides from compounding pharmacies

10/16/2026

The Trump administration is moving forward with a plan to permit compounding pharmacies to manufacture specific peptides, a category of injections that the U.S.

Food and Drug Administration has not approved as safe or effective. The Associated Press reports that these compounds have gained popularity among wellness influencers, including U.S.

Health and Human Services Secretary Robert F.

The administration's proposal would allow these largely unregulated products to be produced by compounding facilities, despite the lack of federal clearance for their safety or efficacy.

Keep reading

Read the full story

Open on NewsDialy